查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
神經科學的抗體及化驗的全球市場 - 2022年～2029年
市場調查報告書
商品編碼
1077226

神經科學的抗體及化驗的全球市場 - 2022年～2029年

Global Neuroscience Antibodies and Assays Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

本報告提供全球神經科學的抗體及化驗市場相關調查，提供市場概要，以及各產品類型，各技術，各終端用戶，各地區趨勢，競爭情形，及加入此市場的主要企業簡介等資訊。

目錄

第1章 神經科學的抗體及化驗市場調查手法和範圍

第2章 神經科學的抗體及化驗市場-市場定義和概要

第3章 神經科學的抗體及化驗市場-摘要整理

  • 各產品類型，市場明細
  • 各技術，市場明細
  • 各終端用戶，市場明細
  • 各地區，市場明細

第4章 神經科學的抗體及化驗市場-市場動態

  • 影響市場的要素
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 影響分析

第5章 神經科學的抗體及化驗市場-產業分析

  • 波特的五力分析
  • 供應鏈分析
  • 價格分析
  • 法規分析
  • 未滿足需求

第6章 神經科學的抗體及化驗市場-COVID-19分析

第7章 神經科學的抗體及化驗市場-各產品類型

  • 簡介
  • 市場規模分析，及與前一年同期比較成長分析(%)、各產品類型
  • 市場魅力指數，各產品類型
    • 消耗品
    • 設備

第8章 神經科學的抗體及化驗市場-各技術

  • 簡介
  • 市場規模分析，及與前一年同期比較成長分析(%)、各技術
  • 市場魅力指數，各技術
    • 免疫測量/免疫化學
    • 分子診斷
    • 其他

第9章 神經科學的抗體及化驗市場-各終端用戶

  • 簡介
    • 市場規模分析，及與前一年同期比較成長分析(%)、各終端用戶
    • 市場魅力指數，各終端用戶
  • 醫藥品及生物科技企業
    • 簡介
    • 市場規模分析，100萬美元(2020年～2029年)，及與前一年同期比較成長分析(%)(2021年～2029年)
    • 學術研究機關
    • 其他

第10章 神經科學的抗體及化驗市場-各地區

  • 簡介
    • 市場規模分析，100萬美元(2020年～2029年)，及與前一年同期比較成長分析(%)(2021年～2029年)，各地區
    • 市場魅力指數，各地區
  • 北美
  • 歐洲
  • 南美
  • 亞太地區
  • 中東·非洲

第11章 神經科學的抗體及化驗市場-競爭情形

  • 主要的發展與策略
  • 企業佔有率分析
  • 產品的基準

第12章 神經科學的抗體及化驗市場-企業簡介

  • Thermo Fisher Scientific
  • Bio-Rad Laboratories, Inc
  • Merck KGaA
  • F. Hoffmann-La Roche
  • Cell Signaling Technology, Inc
  • BioLegend, Inc
  • Abcam Plc
  • Rockland Immunochemicals, Inc
  • GenScript
  • Santa Cruz Biotechnology, Inc.

第13章 神經科學的抗體及化驗市場-DataM

簡介目錄
Product Code: DMOT5028

Market Overview

The global neuroscience antibodies and assays market size was valued at US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX % during the forecast period (2022-2029).

Antibodies are used extensively in neuroscience research to help identify and elucidate reactions at the cellular, molecular, and biochemical levels, leading to a better understanding of various neuronal processes and diseases.

Market Dynamics

The factors expected to drive the global neuroscience antibodies and assays market are the increasing demand for antibodies and assays for neuroscience and a significant increase in the incidence of neurological diseases.

The increasing demand for antibodies and assays for neuroscience is expected to drive the market growth

The field of developmental neuroscience has a long and illustrious history. Recent advances in protein isolation and molecular biology have made it much easier to identify neural-specific developmental processes, allowing for significant progress in the field. As a result, novel neural proteins involved in the development and maturation of various systems make up a large portion of the new targets investigated thus far. For instance, Merck has a wide range of antibodies, kits, and assays to help with developmental neuroscience research.

Moreover, antibodies are used in neurobiology research for a variety of purposes. Each application helps researchers better understand the structure and function of specialised cells in the nervous system. Some of the applications are Western blotting detection, Immunohistochemistry, immunocytochemistry, and immunofluorescence to visualise live and fixed cells or tissues. Immunoprecipitation is used to enrich proteins and study protein interactions. Flow cytometry and FACS quantify, characterize, identify, and isolate cell types/populations. In neurobiology, antibodies investigate neuronal markers, cellular differentiation, and disease markers in the nervous system. In complex cellular systems like neurons, target-specific antibodies can aid in detecting low-abundance proteins.

COVID-19 Impact Analysis

Pharmaceutical and biotech companies are working to combat the COVID-19 outbreak, from vaccine development to planning for challenges in the pharmaceutical supply chain, in collaboration with governments worldwide. Approximately 115 vaccine candidates and 155 molecules are currently being developed in the R&D pipeline. Manufacturers of COVID-19 management drugs have a lot of opportunities due to the high demand for these drugs, as many developed countries are running out of them. Because of the demand for COVID-19 vaccines and treatment drugs, the global neuroscience antibodies and assays market is expected to be impacted.

Segment Analysis

Immunoassays segment is expected to dominate the market growth in the forecast period

Immunoassays are chemical tests that use an antibody or an antigen to determine the presence or concentration of a macromolecule or a small molecule in a solution. Immunoassays are widely used in various settings, including disease diagnosis, therapeutic drug monitoring, and pharmacokinetic and bioequivalence studies in drug development. According to WHO, neurological disorders affect hundreds of millions worldwide, including more than 50 million people with epilepsy and around 47 million people with dementia.

Due to the development of novel antibodies, technological advancements in immunoassays, and increasing government initiatives in the genomics and proteomics research field, the segment holds a significant market share in the neuroscience antibodies and assays market, expected to show a similar trend over the forecast period. The immunoassays segment is being driven by the rising incidence of neurological diseases, technological advancements in immunoassays, and increased research and development activities.

Geographical Analysis

North America region is expected to hold the largest market share in the global neuroscience antibodies and assays market

The rising incidence of neurological diseases, an increase in research and development activities, and growth in the pharmaceutical and biotechnology industries in this region are expected to drive the market growth.

According to Pan American Health Organization (PAHO), in 2019, neurological conditions accounted for the following there were 533,172 deaths, with 213,129 (40%) men and 320,043 (60%) women. 32.9 deaths per 100,000 people (age-standardized), with men suffering 33.1 deaths per 100,000 people and women suffering 32.2 deaths per 100,000 people. Alzheimer's disease and other dementias affect millions of people in the United States. As the number of people aged 65 and up in the United States grows, so will the number of people with Alzheimer's disease or other dementias. The number and proportion of Americans aged 65 and older are expected to rapidly increase in the coming years, rising from 56 million in 2020 to 88 million by 2050. In 2020, an estimated 5.8 million Americans aged 65 and up were diagnosed with Alzheimer's disease. Eighty percent of the population is 75 years old or older.

Competitive Landscape

The global neuroscience antibodies and assays market is moderately competitive, with increasing mergers, acquisitions, and collaborations are expected to drive the market growth. Some of the key players in the market are Thermo Fisher Scientific, Bio-Rad Laboratories, Inc, Merck KGaA, F. Hoffmann-La Roche, Cell Signaling Technology, Inc, BioLegend, Inc, Abcam Plc, Rockland Immunochemicals, Inc, GenScript, Santa Cruz Biotechnology, Inc

Thermo Fisher Scientific

Overview: Thermo Fisher Scientific is scientific instrumentation, reagents and consumables, and software services company based in the United States. The company is based in Waltham, Massachusetts. The company was founded in 1956.

Product Portfolio: For neuroscience research, the company has a wide range of highly specific antibodies validated for various applications. Depending on the type of research, neurobiology antibodies cover a wide range of targets and markers.

Why Purchase the Report?

Visualize the composition of the global neuroscience antibodies and assays market segmentation by product type, by technology, and end-user highlighting the key commercial assets and players.

Identify commercial opportunities in global neuroscience antibodies and assays market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of global neuroscience antibodies and assays market- level 4/5 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for the key product of all major market players

The global neuroscience antibodies and assays market report would provide an access to an approx. 45+market data table, 40+figures and 180 pages.

Target Audience

Service Providers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies

Manufacturers

Table of Contents

1. Neuroscience Antibodies and Assays Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Neuroscience Antibodies and Assays Market- Market Definition and Overview

3. Neuroscience Antibodies and Assays Market- Executive Summary

  • 3.1. Market Snippet By Product Type
  • 3.2. Market Snippet By Technology
  • 3.3. Market Snippet By End User
  • 3.4. Market Snippet By Region

4. Neuroscience Antibodies and Assays Market-Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers:
      • 4.1.1.1. The increasing demand for antibodies and assays for neuroscience
    • 4.1.2. Restraints:
      • 4.1.2.1. High Cost Associated with the Production of Antibodies
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Neuroscience Antibodies and Assays Market- Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Unmet Needs

6. Neuroscience Antibodies and Assays Market- COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Neuroscience Antibodies and Assays Market- By Product Type

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 7.3. Market Attractiveness Index, By Product Type
    • 7.3.1. Consumables
      • 7.3.1.1.1. Introduction
      • 7.3.1.1.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
    • 7.3.2. Instruments

8. Neuroscience Antibodies and Assays Market-By Technology

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
  • 8.3. Market Attractiveness Index, By Technology
    • 8.3.1. Immunoassays/Immunochemistry*
      • 8.3.1.1.1. Introduction
      • 8.3.1.1.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
    • 8.3.2. Molecular Diagnostics
    • 8.3.3. Other

9. Neuroscience Antibodies and Assays Market- By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Pharmaceutical and Biotechnology Companies*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
    • 9.2.3. Academic and Research Institutes
    • 9.2.4. Other

10. Neuroscience Antibodies and Assays Market- By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

11. Neuroscience Antibodies and Assays Market- Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking

12. Neuroscience Antibodies and Assays Market- Company Profiles

  • 12.1. Thermo Fisher Scientific *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Bio-Rad Laboratories, Inc
  • 12.3. Merck KGaA
  • 12.4. F. Hoffmann-La Roche
  • 12.5. Cell Signaling Technology, Inc
  • 12.6. BioLegend, Inc
  • 12.7. Abcam Plc
  • 12.8. Rockland Immunochemicals, Inc
  • 12.9. GenScript
  • 12.10. Santa Cruz Biotechnology, Inc.

LIST NOT EXHAUSTIVE

13. Neuroscience Antibodies and Assays Market- DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us